Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MediCabilis CBD Oil in ALS/MND
NCT03690791Phase 3Unknown
- Sponsor
- Gold Coast Hospital and Health Service
- Start
- Jan 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of medicabilis cbd oil in amyotrophic lateral sclerosis (ALS), sponsored by Gold Coast Hospital and Health Service. Status: unknown.
02
Drugs
medicabilis cbd oil
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03690791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03690791.